ATLANTA, GEORGIA / ACCESS Newswire / October 7, 2025 / Dogwood Therapeutics, Inc. (Nasdaq:DWTX) (the "Company"), a development-stage biotechnology company…
BOULDER, COLORADO / ACCESS Newswire / October 7, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and…
NEW HAVEN, CONNECTICUT / ACCESS Newswire / October 7, 2025 / Momentum Consulting today announced a new collaboration with clinical…
Icotrokinra met the primary endpoint of clinical response at all three doses, with 36.5% of patients treated achieving endoscopic improvement…
EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A PANEL DISCUSSIONThe Summit theme "unlocking the $1 Trillion Wealth transfer…
Findings show that Telomir-1 restores the body's natural tumor suppressor defenses by reversing abnormal DNA methylation of MASPIN and RASSF1A…
Celebrating the vital role pharmacists play in patient health PALM SPRINGS, CALIFORNIA / ACCESS Newswire / October 7, 2025 /…
Pilot Evaluation: Toronto Heart Centre to conduct comparative testing of CardioYield™ for enhanced Holter ECG analysis and reporting efficiency.Clinical Workflow…
Parexel’s Site Alliance Program strengthens global partnerships with clinical research sites and reinforces leadership in site engagement excellenceRALEIGH, N.C., Oct.…
ARLINGTON, Va., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to…